The Asia Pacific AI In Cancer Diagnostics Market would witness market growth of 29.6% CAGR during the forecast period (2022-2028).
Diagnosis of cancer starts with a complete body examination along with an entire medical report of the patient. As cancer is being detected, imaging procedures such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, fiber-optic endoscopy, and X-ray assist doctors to find the cancer location and size of the tumor.
In most cases to detect cancer, biopsy treatment is tested in humans in which a tissue specimen is detached from the diagnosis tumor and researched within a microscope to identify cancer cells in the body. As the testing of cancer comes out as positive, other tests are performed to deliver accurate cancer information. The following process is termed the staging where all the crucial information such as the spread of cancer in the body is acknowledged.
For example, a group of various researchers developed a methylation-based classifier that was originally designed to categorize subtypes of medulloblastomas. Later on, the project was expanded by the German-led team to include more than 100 extra cancers of the central nervous system. After the result of the reports were announced in March 2018, afterward, scientists introduced classifiers for the entire marketplace.
Head and neck cancer are the third most common cancer in India with about 52 067 mortalities and 77 000 diagnoses in 2012. Moreover, in China, caretaking of the cancer patient with non-disclosure of diagnosis to the patients is one of the most serious problems. As per the Law of the People’s Republic of China Medical professionals, or practitioners should open up with the truth to the patients and their caretakers. The law forces a legal authority on a medical specialist for a negative effect on the patient due to the resulting disclosure of diagnosis.
The China market dominated the Asia Pacific AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $36 million by 2028. The Japan market is registering CAGR of 28.8% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 30.4% during (2022 - 2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide AI In Cancer Diagnostics Market is Projected to reach USD 509 Million by 2028, at a CAGR of 28.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Scope of the Study
Market Segments Covered in the Report:
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific AI In Cancer Diagnostics Market, by End-user
1.4.2 Asia Pacific AI In Cancer Diagnostics Market, by Component
1.4.3 Asia Pacific AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 Asia Pacific AI In Cancer Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
Chapter 4. Asia Pacific AI In Cancer Diagnostics Market by End-user
4.1 Asia Pacific Hospital Market by Country
4.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific AI In Cancer Diagnostics Market by Component
5.1 Asia Pacific Software Solutions Market by Country
5.2 Asia Pacific Hardware Market by Country
5.3 Asia Pacific Services Market by Country
Chapter 6. Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
6.1 Asia Pacific Breast Cancer Market by Country
6.2 Asia Pacific Lung Cancer Market by Country
6.3 Asia Pacific Brain Tumor Market by Country
6.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
6.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
6.6 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific AI In Cancer Diagnostics Market by Country
7.1 China AI In Cancer Diagnostics Market
7.1.1 China AI In Cancer Diagnostics Market by End-user
7.1.2 China AI In Cancer Diagnostics Market by Component
7.1.3 China AI In Cancer Diagnostics Market by Cancer Type
7.2 Japan AI In Cancer Diagnostics Market
7.2.1 Japan AI In Cancer Diagnostics Market by End-user
7.2.2 Japan AI In Cancer Diagnostics Market by Component
7.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
7.3 India AI In Cancer Diagnostics Market
7.3.1 India AI In Cancer Diagnostics Market by End-user
7.3.2 India AI In Cancer Diagnostics Market by Component
7.3.3 India AI In Cancer Diagnostics Market by Cancer Type
7.4 South Korea AI In Cancer Diagnostics Market
7.4.1 South Korea AI In Cancer Diagnostics Market by End-user
7.4.2 South Korea AI In Cancer Diagnostics Market by Component
7.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
7.5 Singapore AI In Cancer Diagnostics Market
7.5.1 Singapore AI In Cancer Diagnostics Market by End-user
7.5.2 Singapore AI In Cancer Diagnostics Market by Component
7.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
7.6 Malaysia AI In Cancer Diagnostics Market
7.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
7.6.2 Malaysia AI In Cancer Diagnostics Market by Component
7.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
7.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
7.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
7.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
7.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.4.2.2 Acquisition and Mergers:
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Product Launches and Product Expansions:
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 2 Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– AI In Cancer Diagnostics Market
TABLE 4 Product Launches And Product Expansions– AI In Cancer Diagnostics Market
TABLE 5 Acquisition and Mergers– AI In Cancer Diagnostics Market
TABLE 6 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 7 Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 8 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Thousands
TABLE 9 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Thousands
TABLE 10 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
TABLE 11 Asia Pacific Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
TABLE 12 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 13 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 14 Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 15 Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 16 Asia Pacific Software Solutions Market by Country, 2018 - 2021, USD Thousands
TABLE 17 Asia Pacific Software Solutions Market by Country, 2022 - 2028, USD Thousands
TABLE 18 Asia Pacific Hardware Market by Country, 2018 - 2021, USD Thousands
TABLE 19 Asia Pacific Hardware Market by Country, 2022 - 2028, USD Thousands
TABLE 20 Asia Pacific Services Market by Country, 2018 - 2021, USD Thousands
TABLE 21 Asia Pacific Services Market by Country, 2022 - 2028, USD Thousands
TABLE 22 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 23 Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 24 Asia Pacific Breast Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 25 Asia Pacific Breast Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 26 Asia Pacific Lung Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 27 Asia Pacific Lung Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 28 Asia Pacific Brain Tumor Market by Country, 2018 - 2021, USD Thousands
TABLE 29 Asia Pacific Brain Tumor Market by Country, 2022 - 2028, USD Thousands
TABLE 30 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 31 Asia Pacific Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 32 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 33 Asia Pacific Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 34 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 35 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 36 Asia Pacific AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 37 Asia Pacific AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 38 China AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 39 China AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 40 China AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 41 China AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 42 China AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 43 China AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 44 China AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 45 China AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 46 Japan AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 47 Japan AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 48 Japan AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 49 Japan AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 50 Japan AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 51 Japan AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 52 Japan AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 53 Japan AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 54 India AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 55 India AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 56 India AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 57 India AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 58 India AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 59 India AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 60 India AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 61 India AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 62 South Korea AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 63 South Korea AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 64 South Korea AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 65 South Korea AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 66 South Korea AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 67 South Korea AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 68 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 69 South Korea AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 70 Singapore AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 71 Singapore AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 72 Singapore AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 73 Singapore AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 74 Singapore AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 75 Singapore AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 76 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 77 Singapore AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 78 Malaysia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 79 Malaysia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 80 Malaysia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 81 Malaysia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 82 Malaysia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 83 Malaysia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 84 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 85 Malaysia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 86 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
TABLE 87 Rest of Asia Pacific AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
TABLE 88 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
TABLE 89 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
TABLE 90 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
TABLE 91 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
TABLE 92 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
TABLE 93 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
TABLE 94 key information – Microsoft Corporation
TABLE 95 Key Information – Flatiron Health
TABLE 96 Key Information –Paige AI, Inc.
TABLE 97 Key Information – PathAI, Inc.
TABLE 98 Key Information –Therapixel
TABLE 99 Key Information – Tempus, Inc.
TABLE 100 Key Information – SkinVision BV
TABLE 101 Key Information – Cancer Center Sp. z o.o.
TABLE 102 Key Information – Medial EarlySign
TABLE 103 Key Information – Kheiron Medical Technologies Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
FIG 5 SWOT Analysis: Microsoft Corporation
FIG 6 Recent strategies and developments: Paige AI, Inc.
FIG 7 Recent strategies and developments: PathAI, Inc.